Chemokines and atherosclerosis.

[1]  B. Rollins,et al.  Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[2]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[3]  P. Murphy,et al.  Differential effects of leukotactin-1 and macrophage inflammatory protein-1 alpha on neutrophils mediated by CCR1. , 1999, Journal of immunology.

[4]  N. Maeda,et al.  Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. , 1999, Atherosclerosis.

[5]  K. Preissner,et al.  Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[6]  K. Burnand,et al.  Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. , 1999, The American journal of pathology.

[7]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[8]  A. Zlotnik,et al.  Recent advances in chemokines and chemokine receptors. , 1999, Critical reviews in immunology.

[9]  O. Quehenberger,et al.  Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[10]  R. Alexander,et al.  Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. , 1998, Circulation research.

[11]  C. Power,et al.  Definition, function and pathophysiological significance of chemokine receptors. , 1998, Trends in pharmacological sciences.

[12]  S. Bhakdi,et al.  Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[13]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[14]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[15]  P. Libby,et al.  The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. , 1998, Trends in cardiovascular medicine.

[16]  H. Nomiyama,et al.  EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. , 1998, International immunology.

[17]  O. Yoshie,et al.  Identification of Single C Motif-1/Lymphotactin Receptor XCR1* , 1998, The Journal of Biological Chemistry.

[18]  J. Harrison,et al.  Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[19]  M. Baggiolini,et al.  HCC-2, a human chemokine: gene structure, expression pattern, and biological activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[21]  P. Libby,et al.  CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.

[22]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[23]  A. Roach,et al.  Human vascular smooth muscle cells express receptors for CC chemokines. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[24]  H. Gabbert,et al.  Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[25]  E. Ohlstein,et al.  Chemokine Receptors in Human Endothelial Cells , 1998, The Journal of Biological Chemistry.

[26]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[27]  W. Erl,et al.  Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. , 1998, Atherosclerosis.

[28]  R. Strieter,et al.  The role of CXC chemokines in the regulation of angiogenesis in association with lung cancer. , 1998, Trends in cardiovascular medicine.

[29]  E. Butcher,et al.  Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.

[30]  R. Terkeltaub,et al.  A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.

[31]  M. Volin,et al.  Chemokine receptor CXCR4 expression in endothelium. , 1998, Biochemical and biophysical research communications.

[32]  S. Su,et al.  Chemokines, receptors, and their role in cardiovascular pathology , 1998, International journal of clinical & laboratory research.

[33]  R. Nibbs,et al.  Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* , 1997, The Journal of Biological Chemistry.

[34]  D. H. Park,et al.  Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. , 1997, Journal of immunology.

[35]  G. McFadden,et al.  New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road. , 1997, Biochemical pharmacology.

[36]  James J. Campbell,et al.  Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis , 1997, The Journal of cell biology.

[37]  R. Bravo,et al.  Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor , 1997, The Journal of experimental medicine.

[38]  Robert V Farese,et al.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.

[39]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[40]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Steiner,et al.  Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. , 1997, DNA and cell biology.

[42]  A. Roach,et al.  Chemokine production by human vascular smooth muscle cells: modulation by IL‐13 , 1997, British journal of pharmacology.

[43]  G. Hansson.  Cell-mediated immunity in atherosclerosis , 1997, Current opinion in lipidology.

[44]  M. Peitsch,et al.  Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. , 1997, European journal of biochemistry.

[45]  A. Becker,et al.  Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. , 1997, Atherosclerosis.

[46]  M. Ridanpää,et al.  Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13* , 1997, The Journal of Biological Chemistry.

[47]  Y. Sakaki,et al.  A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. , 1997, Journal of immunology.

[48]  T. Warner,et al.  Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[49]  E. Hurt-Camejo,et al.  Potential involvement of type II phospholipase A2 in atherosclerosis. , 1997, Atherosclerosis.

[50]  H. Sarau,et al.  Cloning, in Vitro Expression, and Functional Characterization of a Novel Human CC Chemokine of the Monocyte Chemotactic Protein (MCP) Family (MCP-4) That Binds and Signals through the CC Chemokine Receptor 2B* , 1997, The Journal of Biological Chemistry.

[51]  T. Mcclanahan,et al.  A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.

[52]  H. Nomiyama,et al.  Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.

[53]  K. Murao,et al.  Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines* , 1997, The Journal of Biological Chemistry.

[54]  P. Libby,et al.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Farber.  Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[56]  Osamu Yoshie,et al.  Molecular Cloning of a Novel Human CC Chemokine Liver and Activation-regulated Chemokine (LARC) Expressed in Liver , 1997, The Journal of Biological Chemistry.

[57]  K. Chung,et al.  Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. , 1997, Journal of immunology.

[58]  H. Nomiyama,et al.  Assignment of the human CC chemokine gene TARC (SCYA17) to chromosome 16q13. , 1997, Genomics.

[59]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[60]  S. J. Myers,et al.  Organization and Differential Expression of the Human Monocyte Chemoattractant Protein 1 Receptor Gene , 1997, The Journal of Biological Chemistry.

[61]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[62]  M. Reale,et al.  Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. , 1997, Journal of vascular research.

[63]  Q. Hamid,et al.  Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. , 1996, Journal of immunology.

[64]  P. Huie,et al.  RANTES chemokine expression in transplant-associated accelerated atherosclerosis. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[65]  T. Yue,et al.  Interferon-inducible Protein-10 Involves Vascular Smooth Muscle Cell Migration, Proliferation, and Inflammatory Response* , 1996, The Journal of Biological Chemistry.

[66]  M. Dorf,et al.  Beta-chemokine TCA3 binds to and activates rat vascular smooth muscle cells. , 1996, Journal of immunology.

[67]  P. Norman,et al.  Monocyte chemoattractant protein‐1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages , 1996, Journal of cellular biochemistry.

[68]  O. Yoshie,et al.  Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.

[69]  P. Tipping,et al.  Interleukin-8 production by macrophages from atheromatous plaques. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[70]  T. Shimokama,et al.  Inflammatory and immunological nature of atherosclerosis. , 1996, International journal of cardiology.

[71]  P. Murphy.  Chemokine receptors: structure, function and role in microbial pathogenesis. , 1996, Cytokine & growth factor reviews.

[72]  H. Maegawa,et al.  Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. , 1996, Metabolism: clinical and experimental.

[73]  R. Sayers,et al.  Angiogenesis in abdominal aortic aneurysms. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[74]  B. Dewald,et al.  Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.

[75]  A. Tall,et al.  Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.

[76]  A. Weyrich,et al.  Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.

[77]  P. Proost,et al.  The role of chemokines in inflammation , 1996, International journal of clinical & laboratory research.

[78]  G. Hansson,et al.  Immunological mechanisms in atherosclerosis , 1995, Journal of internal medicine.

[79]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[80]  J. Inazawa,et al.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. , 1995, Genomics.

[81]  T. Schall,et al.  Molecular cloning and functional characterization of human lymphotactin. , 1995, Journal of immunology.

[82]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  U. Ikeda,et al.  Monocyte chemoattractant protein 1 inhibits growth of rat vascular smooth muscle cells. , 1995, The American journal of physiology.

[84]  D. Taub,et al.  Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. , 1995, The Journal of clinical investigation.

[85]  T. Schall,et al.  Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. , 1995, Journal of immunology.

[86]  T. Fan,et al.  Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. , 1995, Trends in pharmacological sciences.

[87]  D. Taub,et al.  Modulation of IL‐8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL‐8 , 1995, Journal of leukocyte biology.

[88]  B. Dewald,et al.  Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytes , 1995 .

[89]  D. Graves,et al.  Chemokines, a family of chemotactic cytokines. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[90]  T. Schall,et al.  Chemokines, leukocyte trafficking, and inflammation. , 1994, Current opinion in immunology.

[91]  R. Strieter,et al.  Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. , 1994, The American journal of pathology.

[92]  S M Schwartz,et al.  Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.

[93]  M. Gimbrone,et al.  Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. , 1994, The Journal of clinical investigation.

[94]  T. Yue,et al.  Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. , 1994, Circulation research.

[95]  S Chien,et al.  Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[96]  R. Horuk.  Molecular properties of the chemokine receptor family. , 1994, Trends in pharmacological sciences.

[97]  T. Springer,et al.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[98]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[99]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.

[100]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[101]  T. Schall,et al.  Local expression of inflammatory cytokines in human atherosclerotic plaques. , 1994, Journal of atherosclerosis and thrombosis.

[102]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[103]  R. Terkeltaub,et al.  Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[104]  R. Ross,et al.  Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. , 1993, The American journal of pathology.

[105]  C. Chang,et al.  Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. , 1993, Biochimica et biophysica acta.

[106]  W. Pearce,et al.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, The American journal of pathology.

[107]  E. Leonard,et al.  Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.

[108]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[109]  D. Taub,et al.  Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta , 1993, Science.

[110]  G. Bondjers,et al.  Endothelial integrity and injury in atherogenesis. , 1993, Transplantation proceedings.

[111]  R. Ross,et al.  Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. , 1993, British heart journal.

[112]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[113]  A. J. Valente,et al.  Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[114]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[115]  B. Rollins,et al.  JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. , 1992, Circulation research.

[116]  E. Butcher.  Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity , 1991, Cell.

[117]  G. Hansson,et al.  Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[118]  S. Coughlin,et al.  Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.

[119]  H. Rus,et al.  Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. , 1991, Atherosclerosis.

[120]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[121]  D. Goeddel,et al.  Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES , 1990, Nature.

[122]  A. J. Valente,et al.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[123]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[124]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[125]  J. Shabanowitz,et al.  Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[126]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[127]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.